These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 16990797)

  • 1. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.
    Ciana P; Fumagalli M; Trincavelli ML; Verderio C; Rosa P; Lecca D; Ferrario S; Parravicini C; Capra V; Gelosa P; Guerrini U; Belcredito S; Cimino M; Sironi L; Tremoli E; Rovati GE; Martini C; Abbracchio MP
    EMBO J; 2006 Oct; 25(19):4615-27. PubMed ID: 16990797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17.
    Daniele S; Lecca D; Trincavelli ML; Ciampi O; Abbracchio MP; Martini C
    Cell Signal; 2010 Apr; 22(4):697-706. PubMed ID: 20056144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands.
    Daniele S; Trincavelli ML; Gabelloni P; Lecca D; Rosa P; Abbracchio MP; Martini C
    J Pharmacol Exp Ther; 2011 Aug; 338(2):559-67. PubMed ID: 21531793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
    Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
    PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is GPR17 a P2Y/leukotriene receptor? examination of uracil nucleotides, nucleotide sugars, and cysteinyl leukotrienes as agonists of GPR17.
    Qi AD; Harden TK; Nicholas RA
    J Pharmacol Exp Ther; 2013 Oct; 347(1):38-46. PubMed ID: 23908386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats.
    Zhao B; Zhao CZ; Zhang XY; Huang XQ; Shi WZ; Fang SH; Lu YB; Zhang WP; Xia Q; Wei EQ
    Neuroscience; 2012 Jan; 202():42-57. PubMed ID: 22155652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
    Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
    BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury.
    Ceruti S; Villa G; Genovese T; Mazzon E; Longhi R; Rosa P; Bramanti P; Cuzzocrea S; Abbracchio MP
    Brain; 2009 Aug; 132(Pt 8):2206-18. PubMed ID: 19528093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Orphan Receptor GPR17 Is Unresponsive to Uracil Nucleotides and Cysteinyl Leukotrienes.
    Simon K; Merten N; Schröder R; Hennen S; Preis P; Schmitt NK; Peters L; Schrage R; Vermeiren C; Gillard M; Mohr K; Gomeza J; Kostenis E
    Mol Pharmacol; 2017 May; 91(5):518-532. PubMed ID: 28254957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells.
    Pugliese AM; Trincavelli ML; Lecca D; Coppi E; Fumagalli M; Ferrario S; Failli P; Daniele S; Martini C; Pedata F; Abbracchio MP
    Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1028-40. PubMed ID: 19625605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
    Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
    Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia.
    Ballerini P; Di Iorio P; Ciccarelli R; Caciagli F; Poli A; Beraudi A; Buccella S; D'Alimonte I; D'Auro M; Nargi E; Patricelli P; Visini D; Traversa U
    Int J Immunopathol Pharmacol; 2005; 18(2):255-68. PubMed ID: 15888248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.
    Capra V; Ravasi S; Accomazzo MR; Citro S; Grimoldi M; Abbracchio MP; Rovati GE
    J Cell Sci; 2005 Dec; 118(Pt 23):5625-36. PubMed ID: 16306225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
    Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
    Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
    Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal expression of cysteinyl leukotriene receptor-2 mRNA in rat brain after focal cerebral ischemia.
    Fang SH; Zhou Y; Chu LS; Zhang WP; Wang ML; Yu GL; Peng F; Wei EQ
    Neurosci Lett; 2007 Jan; 412(1):78-83. PubMed ID: 17196746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation.
    Fumagalli M; Daniele S; Lecca D; Lee PR; Parravicini C; Fields RD; Rosa P; Antonucci F; Verderio C; Trincavelli ML; Bramanti P; Martini C; Abbracchio MP
    J Biol Chem; 2011 Mar; 286(12):10593-604. PubMed ID: 21209081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.
    Bäck M; Dahlén SE; Drazen JM; Evans JF; Serhan CN; Shimizu T; Yokomizo T; Rovati GE
    Pharmacol Rev; 2011 Sep; 63(3):539-84. PubMed ID: 21771892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction.
    Cosentino S; Castiglioni L; Colazzo F; Nobili E; Tremoli E; Rosa P; Abbracchio MP; Sironi L; Pesce M
    J Cell Mol Med; 2014 Sep; 18(9):1785-96. PubMed ID: 24909956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.